A rare and improbable mutation in a protein encoded by an influenza virus renders the virus defenseless against the body’s immune system. This University of Rochester Medical Center discovery could provide a new strategy for live influenza vaccines in the future.
A new approach to the live flu vaccine would be particularly advantageous right now after the Centers for Disease Control and Prevention stopped recommending use of the live attenuate flu vaccine, FluMist® earlier this year. Several studies found that the pain-free nasal spray, which was used in about one-third of young children in the U.S., offered no protection to that especially vulnerable population. The flu shot, on the other hand, performed well and the CDC recommends using this vaccine in place of FluMist®.
“There is a need to understand what’s happening with the existing live vaccine and potentially a need to develop a new one,” said David Topham, Ph.D., Marie Curran Wilson and Joseph Chamberlain Wilson Professor of Microbiology and Immunology at URMC and author of the study. “We proposed that the mutation we found could be used to create a live vaccine.”
The mutation weakens the flu virus by making the flu-encoded protein, called Non-Structural 1 (NS1), defunct. Flu virus needs NS1 to prevent interferon, the immune system’s front line against viruses, from alerting the host cell that it has been infected. Inhibiting interferon affords the virus time to multiply and spread before the immune system can mount an attack.
Most people have healthy interferon responses and would quickly and easily fend off this weakened mutant strain of flu, but, “this virus somehow managed to find the one person that had an interferon defect that allowed it to replicate,” said Topham.
The probability of this virus surviving and infecting a human is so low – it is as if Topham and lead study author, Marta Lopez de Diego, Ph.D., research assistant professor of Microbiology and Immunology, found a needle in a haystack. The pair isolated the mutated virus from a nasal swab of a single flu sufferer who happened to be among the small percentage of people with inadequate interferon responses. When they looked for the NS1 mutation in a national database, it showed up in just 0.03 percent of all flu strains reported.
This naturally-occurring “attenuating” flu mutation could provide a new way to make live flu vaccines, which contain viruses that are alive, but “attenuated”, or weakened, so the vaccine itself does not cause illness in humans. Topham and Lopez de Diego suspect their NS1 mutation could be a great way to prevent viruses in the live vaccine from infecting anyone who has normal interferon responses, which is most people.
The study, published online in the Journal of Virology, also highlights the importance of flu virus surveillance – conducting studies like Topham’s to see how the flu is changing, what flu mutations are circulating in humans and animals, and how those mutations affect virus function.
Topham believes health leaders are not doing enough of that research. “The influenza field is largely fixated on studying pandemic or potential pandemic viruses, but those viruses only infect a few dozen people every year whereas seasonal flu infects millions – and yet we don’t study human influenzas closely enough.”
In fact, the World Health Organization estimates 1 billion flu infections each year, causing 300,000 to 500,000 deaths.
Until recently, researchers believed that proteins like NS1 did not change much from strain to strain and season to season, but Topham’s study and others show that NS1 mutations occur naturally and can affect its ability to suppress immunity. Monitoring for these mutations in nature could help us produce better vaccines that save more lives.
Learn more: URMC Researchers Discover Rare Flu-Thwarting Mutation
The Latest on: Influenza
[google_news title=”” keyword=”influenza” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Influenza
- Is avian influenza a threat to the dairy industry?on May 1, 2024 at 11:32 pm
The ongoing highly pathogenic H5N1 avian influenza – commonly known as bird flu – outbreak is one of the hardest hitting in history. Since 2020, it has led to the deaths of “an unprecedented number of ...
- Researchers document Florida dolphin with avian influenzaon May 1, 2024 at 2:19 pm
Discovered in 2022, this bottlenose mammal was the first cetacean in North America to test positive for the H5N1 virus.
- IDOA and IDPH Monitoring HSN1 Influenza In Dairy Cattleon May 1, 2024 at 9:48 am
SPRINGFIELD While no cases have been reported in Illinois, federal agencies confirmed the detection of H5N1 influenza virus in dairy herds in eight states ...
- Disease Severity in Hospitalized Adults: RSV vs COVID-19 vs Influenzaon May 1, 2024 at 6:41 am
Researchers compared the disease severity of unvaccinated adults hospitalized with RSV with that of vaccinated and unvaccinated inpatients with COVID-19 and influenza.
- New research reveals speed of avian influenza transmissionon May 1, 2024 at 5:12 am
One Health Poultry Hub, including researchers from the Royal Veterinary College (RVC) has, for the first time, modelled the transmission of avian influenza, commonly called bird flu, revealing the ...
- Spikes of flu virus in wastewater raise questions about spread of bird fluon April 30, 2024 at 10:36 am
Spikes of influenza A virus seen in wastewater samples from 59 sewer systems across 18 different states this spring may point to the spread of the H5N1 avian influenza virus that is currently ...
- Swine industry concerned about avian influenzaon April 29, 2024 at 8:25 pm
Pig farmers are concerned swine could be susceptible to highly pathogenic avian influenza. Brennen Toquam of Blooming Prairie in southeast Minnesota tells Brownfield there are many unknowns with the ...
- USDA actions to protect livestock health from highly pathogenic H5N1 avian influenzaon April 29, 2024 at 6:57 pm
To further protect the U.S. livestock industry from the threat posed by highly pathogenic H5N1 avian influenza, USDA is sharing a number of actions to help get ahead of this disease and limit its ...
- FDA reports fragments of avian influenza found in US commercial milk supplyon April 29, 2024 at 6:28 pm
The FDA reported last week that one in five milks samples from US retail stores contained fragments of the H5N1 bird flu that has recently infected dairy cows in the US.
via Bing News